Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care
- 24 July 2013
- journal article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Gastroenterology
- Vol. 48 (9), 1048-1054
- https://doi.org/10.3109/00365521.2013.816771
Abstract
Objective. Assessment of faecal calprotectin (fCal) test performance in primary care within an irritable bowel syndrome (IBS) diagnostic pathway. Methods. Study based on consecutively collected fCal data from 962 patients, aged 18–45, presenting to their general practitioner (GP) with persistent gastrointestinal symptoms. Results. Six hundred and eighty six (71%) patients had a negative (<50 μg/g) and 276 (29%) had a positive fCal. 28% (77/276) of the patients testing positive and 3% (17/686) of those testing negative had an organic diagnosis. At 50 μg/g the sensitivity of the test for organic disease was 82%, (95% confidence interval [CI] 73–89) and the specificity was 77% (95% CI 74–80), with negative predictive value (NPV) and positive predictive value (PPV) of 98% and 28%, respectively. A cut-off increase to 150 μg/g reduces the NPV by 1% whilst increasing the PPV to 71%. This would reduce colonoscopy and flexible sigmoidoscopy bookings by 10% at the cost of four missed cases of inflammatory bowel disease. Conclusions. This study provides the first evidence on the use of fCal testing in primary care. The low prevalence of organic disease in this setting has a significant impact on test performance. This suggests a need for change in cut-off value, to improve PPV whilst accepting a reduction in test sensitivity, if it is to be used as part of the pathway for management of patients with suspected IBS.Keywords
This publication has 15 references indexed in Scilit:
- Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational studyBMC Gastroenterology, 2012
- Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisBMJ, 2010
- Faecal calprotectin in colonic diverticular disease: a case–control studyInternational Journal of Colorectal Disease, 2008
- Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceGut, 2007
- The Functional Gastrointestinal Disorders and the Rome III ProcessGastroenterology, 2006
- Functional Bowel DisordersGastroenterology, 2006
- Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiologyAlimentary Pharmacology & Therapeutics, 2004
- Role of faecal calprotectin as non-invasive marker of intestinal inflammationDigestive and Liver Disease, 2003
- A simple method for assessing intestinal inflammation in Crohn's diseaseGut, 2000
- Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic StudyScandinavian Journal of Gastroenterology, 1992